about
AMP-activated protein kinase, stress responses and cardiovascular diseasesPeroxisome proliferator-activated receptor gamma coactivator 1alpha or 1beta overexpression inhibits muscle protein degradation, induction of ubiquitin ligases, and disuse atrophyArctigenin efficiently enhanced sedentary mice treadmill enduranceOne-day workshop-based training improves physical activity prescription knowledge in Latin American physicians: a pre-test post-test studyCellular bioenergetics as a target for obesity therapy.Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.Optimal management of sarcopenia.Peroxisome proliferator-activated receptor {gamma} coactivator 1{alpha} (PGC-1{alpha}) promotes skeletal muscle lipid refueling in vivo by activating de novo lipogenesis and the pentose phosphate pathway.A randomized controlled trial of angiotensin-converting enzyme inhibition for skeletal muscle dysfunction in COPD.Impaired musculoskeletal response to age and exercise in PPARβ(-/-) diabetic miceCurrent and future drug targets in weight managementA study of the effects of exercise on the urinary metabolome using normalisation to individual metabolic output.Muscle-Specific Overexpression of PGC-1α Does Not Augment Metabolic Improvements in Response to Exercise and Caloric RestrictionOf mice and men: the benefits of caloric restriction, exercise, and mimetics.The AMPK activator R419 improves exercise capacity and skeletal muscle insulin sensitivity in obese mice.Utilizing small nutrient compounds as enhancers of exercise-induced mitochondrial biogenesisExercise acts as a drug; the pharmacological benefits of exerciseNeuronal nitric oxide synthase is indispensable for the cardiac adaptive effects of exercise.Dealing with ambiguity: Israeli physician's attitudes and practices regarding pre-exercise certificates: a questionnaire study.Exercise-like effects by Estrogen-related receptor-gamma in muscle do not prevent insulin resistance in db/db mice.Resistance to aerobic exercise training causes metabolic dysfunction and reveals novel exercise-regulated signaling networks.Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations.Lack of adequate appreciation of physical exercise's complexities can pre-empt appropriate design and interpretation in scientific discovery.AMP-activated protein kinase modulators: a patent review (2006 - 2010).AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseasesFrom gene engineering to gene modulation and manipulation: can we prevent or detect gene doping in sports?Targeting vascular (endothelial) dysfunction.Voluntary Running Attenuates Metabolic Dysfunction in Ovariectomized Low-Fit Rats.Catalase activity prevents exercise-induced up-regulation of vasoprotective proteins in venous tissue.PPARgamma agonist pioglitazone does not enhance performance in mice.Effect of increased physical activity on fructose-induced glycemic response in healthy individuals.Obesity Drug Update: The Lost Decade?Chronic β2 -adrenoceptor agonist treatment alters muscle proteome and functional adaptations induced by high intensity training in young men.Emerging drugs: mechanism of action, mass spectrometry and doping control analysis.Concurrent treatment with ursolic acid and low-intensity treadmill exercise improves muscle atrophy and related outcomes in rats.Sedentarismo, exercício físico e doenças crônicas
P2860
Q24610297-2A98BC11-59F0-4AAB-9663-C793E904D281Q24634396-360DECB6-368A-41C6-86B3-9AEA51007CD1Q28476727-2493FEEE-352F-4155-95D3-A48971A0706AQ30396041-981A208D-7752-49AF-BFB5-86DC973E84FBQ33894407-9D92C89D-3167-447C-96B4-7FE13DF6AD1EQ34031701-BCF6F9EC-F58A-4F12-9A1B-9B1CCF8C78C3Q34121822-F42862BA-C930-4960-9C3D-030830F0DBDFQ34236724-EB37A2C2-D037-43C7-8A11-344760D82190Q34299825-9FF6AFCE-756A-4E84-A60B-270B97A07872Q34551710-A623E22A-4337-4F41-B884-F54B05FAAE2AQ35089784-745C9476-26AC-43E3-807E-35CC70472C3CQ35237607-0F9E2BEF-809D-4B0D-95E8-61AE3DD50D9DQ35532249-7744A0A7-F66F-4AF4-A3DD-E18B7133261DQ35973671-031D9B59-1225-465D-84A8-52243B6C3264Q36038197-303EA98A-3592-4F18-93C8-83AEF1F1C623Q36209248-79A4193F-8850-4767-8239-9862C709CFADQ36252826-B4C24A32-52E9-49DF-9365-23C8BF8349C4Q36619416-EA723DE1-26FE-47CA-A546-F2C332974897Q36854677-6B4990F3-B5FA-4C8F-9389-7689AACF41E5Q36933850-44E4AAFF-64A6-47B6-8ADD-92DD5E71AFCBQ37031057-B901144A-3CF6-4FF2-9CEA-877442BE4694Q37531997-C5645368-2B90-4655-A4DF-D31049DE0A68Q37590547-437E7FDF-12C5-497F-8AB1-8554A850054FQ37872742-326D701B-6D6D-403B-926E-289DAA5A2973Q38026549-D3DA49AB-E0EA-443C-A777-08AEA4A09850Q38119906-C5C2636B-D6C9-4A06-B2C6-CB216030FE5DQ38836199-DAEA6ADD-5FBF-4EFA-8876-D52CD444F6A9Q39350536-090878D3-E230-4CAD-9D9E-A3F75C6825CEQ42914451-3715302B-9D06-4CA8-80B8-8FA45BEDB2FDQ44994548-5CABD62F-E8AB-489C-8C8E-AE38889E42A7Q46194234-10F04E17-5FAE-4FF4-91DD-95884C44F3E3Q46972562-BE503B7D-8E24-496B-9866-432FEF019725Q47688453-4C5170F6-17DE-44CB-9C63-CF454ED072A1Q47992683-052BA0DA-357A-4BEF-AC2F-996BDB707175Q55415253-BAB029C2-9CC0-4BEE-9E1C-0852974B8BB0Q57537597-E5AA7186-6362-4FFC-B58B-A2E896BA6C79
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
The exercise pill--too good to be true?
@en
The exercise pill--too good to be true?
@nl
type
label
The exercise pill--too good to be true?
@en
The exercise pill--too good to be true?
@nl
prefLabel
The exercise pill--too good to be true?
@en
The exercise pill--too good to be true?
@nl
P356
P1476
The exercise pill--too good to be true?
@en
P2093
Laurie J Goodyear
P304
P356
10.1056/NEJMCIBR0806723
P407
P577
2008-10-01T00:00:00Z